Search
for
Sort by
Research 30 of 1000+
- Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitis
- Pneumonitis Caused by Metronidazole
- Hypersensitivity Reactions to Anticoagulant Drugs
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Mucocutaneous reactions to chemotherapy
- Psychoactive drugs and skin
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Radioprotection of Lung Tissue by Soy Isoflavones
- Anthelminthic drugs
- The Assessment and Treatment of Geezers
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Sub-acute cutaneous lupus erythematosus following nitrofurantoin: causative or coincidental?
- Cytostatics and immunosuppressive drugs
- Adverse Cutaneous Reactions to Mood Stabilizers
- Alopecia and Amphetamine Use-Reply
- The Assessment and Treatment of Geezers
- Severe cutaneous adverse reactions to drugs
- Drug eruptions in dermatology
- Cutaneous Reactions to Drugs
- Dermatological drugs, topical agents, and cosmetics
- Cutaneous Manifestations of Lupus Erythematosus
- Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease
- Novel causes of drug-induced occupational asthma
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Lupus erythematosus: systemic and cutaneous manifestations
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Methotrexate in dermatology
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System